Expands Phillips Medisize’s inhalation drug delivery capabilities.

Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxtm, today announced ...

Phillips Medisize adds market-leading inhalation capabilities to its existing suite of drug delivery device design and ...

Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRx™, today announced the ...

Whether detecting rising anxiety or managing a full-blown panic attack, the tech industry is offering an array of new tools designed to support mental health.

Hydroxychloroquine is under clinical development by PureIMS and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Using nasal swabs to identify a child’s asthma subtype may lead to more precise medication prescribing and development of ...

On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...

It’s smart to be as ready as you can be for whatever life throws at you, especially when it comes to your family’s healt ...

Vectura Group Limited is a British pharmaceuticals company based in Chippenham, England, which develops inhaled medicines and ...

KOLs interviewed by GlobalData stressed the lack of biologic therapies specifically targeting T2-low asthma.